의료용 일회용품 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 원자재별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Medical Disposables Market Summary

The global medical disposables market size was valued at USD 674.25 billion in 2025 and is projected to reach USD 2,515.23 billion by 2033, growing at a CAGR of 18.02% from 2026 to 2033. The market is witnessing growth, driven by rising demand for safe, hygienic, and cost-effective healthcare solutions. Medical disposables, such as syringes, gloves, catheters, diagnostic kits, and wound care products, are widely used in hospitals, clinics, and home care settings to prevent cross-contamination and ensure patient safety. The market expansion is primarily supported by the rising burden of chronic diseases, the growing number of surgical procedures, and an aging population that requires frequent medical attention.

In addition, heightened awareness of infection prevention, especially following recent global health crises, has significantly accelerated the adoption of single-use products.

The rising prevalence of Hospital-Acquired Infections (HAIs) is a key factor driving growth in the medical disposables market, as healthcare providers prioritize infection prevention and patient safety. HAIs such as bloodstream infections, surgical site infections, and ventilator-associated pneumonia are transmitted through contaminated instruments or improper sterilization, prompting hospitals to shift toward single-use, sterile products. Medical disposables, including gloves, syringes, catheters, surgical drapes, and masks, significantly reduce the risk of cross-contamination compared to reusable equipment. As regulatory bodies enforce stricter hygiene and sterilization standards, hospitals and clinics are compelled to adopt a higher volume of disposable products to ensure compliance and minimize infection rates. In addition, the financial burden of treating HAIs and extended hospital stays further encourages healthcare facilities to invest in cost-effective preventive measures, such as disposables.

According to the WHO, healthcare-associated infections remain a major and persistent challenge worldwide in 2025. They affect about 7% of patients in high-income countries and up to 15% in low- and middle-income nations. These infections not only threaten patient safety but also lead to higher morbidity and mortality rates, along with a decline in quality of life.

The increasing volume of surgical procedures, particularly orthopedic interventions such as hip and knee replacements, is driving significant growth in the medical disposables market. These procedures are becoming more common due to the rising incidence of joint disorders, aging populations, and improved access to advanced surgical care. Each surgery requires a large quantity of single-use products, including surgical gloves, gowns, drapes, syringes, sutures, and sterilization supplies, to maintain a sterile environment and minimize the risk of infections. As the number of joint replacement surgeries continues to increase, hospitals and surgical centers are using more disposable items to ensure patient safety and comply with stringent infection control standards. In addition, the growing preference for minimally invasive techniques and faster recovery procedures is further boosting surgical frequency, thereby accelerating the demand for medical disposables across healthcare settings.

Global Medical Disposables Market Report Segmentation

This report forecasts global, regional, and country-level revenue growth and analyzes the latest industry trends and opportunities across sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global medical disposables market report based on product, raw material, end use, and region:

Product Outlook (Revenue, USD Million, 2021 - 2033)

• Wound Management Products
• Moist
  • Foam Dressings
  • Hydrocolloid Dressings
  • Film Dressings
  • Alginate Dressings
  • Hydrogel Dressings
  • Collagen Dressings
  • Other Advanced Dressings
• Antimicrobial
  • Silver
  • Non-silver
  • Honey
  • Iodine
  • Chitosan
  • PHMB
  • Others
• Surgical Wound Care
  • Sutures & staples
  • Tissue adhesive and sealants
  • Anti-infective dressing
• Traditional Wound Care
  • Medical Tapes
  • Cotton
  • Bandages
  • Gauzes
  • Sponges
  • Cleansing Agents
• Drug Delivery Products
• Inhalers
  • Metered-dose inhalers (MDIs)
  • Dry powder inhalers (DPIs)
• Injection Devices
  • Prefilled syringes
  • Auto-injectors
• Transdermal patches
• Others
• Diagnostic and Laboratory Disposables
• Pipettes
• Tips
• Tubes
• Cuvettes
• Dishes
• Cell Imaging Consumables
• Cell Culture Consumables
• Specimen Containers
• Transport Vials
• Collection and Transport Swabs
• Tissue Collectors
• Optical Grade
• Others
• Dialysis Disposables
• Dialysis Catheters
  • Tunneled catheters
  • Non-tunneled catheters
• AV Access Needles
  • Dialysis fistula needles
  • Safety needles
• Peritoneal Dialysis Consumables
  • PD drainage bags
  • Transfer sets
  • Others
• Incontinence Products
• Absorbent Products
  • Pads & Guards
  • Underwear & Briefs
  • Bed Protectors
  • Diapers
  • Ultra-Absorbent Disposable Diapers
  • Super-Absorbent Disposable Diapers
  • Biodegradable Disposable Diapers
  • Others
  • Other absorbents
• Catheters
  • Intermittent Catheters
  • Indwelling Catheters
  • External Catheters
• Drainage Bags
• Skin Care & Hygiene Products
  • Disposable wipes (incontinence wipes)
  • Cleansing foams
  • Others
• Others
• Respiratory Supplies
• Tracheostomy tubes
• Disposable endotracheal tubes
• Resuscitators
• Disposable oxygen masks
• Oxygen cannula
• Others
• Sterilization Supplies
• Sterilization Indicators
  • Chemical indicators
  • Biological indicators
• Sterilization Packaging Supplies
  • Sterilization wraps
  • Sterilization pouches
  • Sterilization reels
• Disposable Sterilization Accessories
• Non-woven Disposables
• Disposable Masks
• Surgical & Procedure Masks
• Respirator Masks
• Other Medical Masks
• Disposable Eye Gear
• Protective Safety Eyewear
  • Safety glasses
  • Anti-fog safety glasses
  • Splash-resistant goggles
• Surgical & Procedure Eye Protection
• Laser Safety Eyewear (Disposable)
• Post-Operative Eye Protection
• Disposable Gloves
• Examination
• Surgical
• Hand Sanitizers
• Gel
• Foam
• Liquid
• Others
• Others
• Disposable Hospital Gowns
  • Surgical Gowns
  • Fluid Resistant Gowns
  • AAMI-rated
  • Level 1
  • Level 2
  • Level 3
  • Level 4
  • Non-AAMI rated
  • Non-Fluid Resistant Gowns (Non-AAMI rated)
  • Non-Surgical Gowns
  • Patient Gowns
• Emesis Bags
• Shoe Covers & Caps
• Disposable Bed Sheets & Covers
• Others
• Raw Material (Revenue, USD Million, 2021 - 2033)
• Plastic Resin
• Nonwoven Material
• Rubber
• Paper and Paperboard
• Metals
• Glass
• Others
• End Use (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Home Healthcare
• Outpatient/Primary Care Facilities
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Netherlands
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Third Party Perspective
  • 1.3.5. Primary research
  • 1.3.6. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. List of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights Outlook

Chapter 3. Medical Disposables Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
• 3.2. User Perspective Analysis
  • 3.2.1. Consumer behavior analysis
• 3.3. Market Dynamics
  • 3.3.1. Market driver analysis
    • 3.3.1.1. Rising hospitalization and surgical procedures globally
    • 3.3.1.2. Increasing prevalence of chronic diseases
    • 3.3.1.3. Growing focus on infection prevention & control (IPC)
    • 3.3.1.4. Expansion of healthcare infrastructure in emerging markets
    • 3.3.1.5. Rising demand for single-use products to reduce cross-contamination
    • 3.3.1.6. Growth in home healthcare and ambulatory care settings
    • 3.3.1.7. Stringent regulatory guidelines for sterilization and hygiene
    • 3.3.1.8. Increasing incidence of healthcare-associated infections
  • 3.3.2. Market restraint analysis
    • 3.3.2.1. Environmental concerns due to medical waste generation
    • 3.3.2.2. Cost pressure in price-sensitive markets
    • 3.3.2.3. Stringent regulatory approvals and compliance requirements
  • 3.3.3. Market opportunity analysis
    • 3.3.3.1. Growing adoption of biodegradable and sustainable disposables
    • 3.3.3.2. Expansion in emerging economies
    • 3.3.3.3. Increasing demand for advanced wound care & specialty disposables
    • 3.3.3.4. Technological innovations
    • 3.3.3.5. Rising home dialysis and remote patient care
    • 3.3.3.6. Government initiatives to improve healthcare access and hygiene standards
  • 3.3.4. Market challenge analysis
    • 3.3.4.1. Managing medical waste disposal and sustainability issues
    • 3.3.4.2. Balancing cost vs quality in bulk procurement
    • 3.3.4.3. Maintaining consistent supply chain during global disruptions
• 3.4. Medical Disposables Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Technological landscape
    • 3.4.2.3. Economic landscape

Chapter 4. Medical Disposables Market: Product Estimates & Trend Analysis

• 4.1. Definitions and Scope
• 4.2. Product Market Share, 2021 & 2033
• 4.3. Segment Dashboard
• 4.4. Global Medical Disposables Market by Product Outlook
• 4.5. Volume Analysis
• 4.6. ASP Analysis in USD
• 4.7. Market Size & Forecasts and Trend Analyses, 2025 to 2033 for the following
  • 4.7.1. Wound Management Products
    • 4.7.1.1. Wound management products market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.1.2. Moist
      • 4.7.1.2.1. Moist market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
      • 4.7.1.2.2. Foam Dressings
      • 4.7.1.2.3. Hydrocolloid Dressings
      • 4.7.1.2.4. Film Dressings
      • 4.7.1.2.5. Alginate Dressings
      • 4.7.1.2.6. Hydrogel Dressings
      • 4.7.1.2.7. Collagen Dressings
      • 4.7.1.2.8. Other Advanced Dressings
    • 4.7.1.3. Antimicrobial
      • 4.7.1.3.1. Antimicrobial market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
      • 4.7.1.3.2. Silver
      • 4.7.1.3.3. Non-silver
        • 4.7.1.3.3.1. Honey
        • 4.7.1.3.3.2. Iodine
        • 4.7.1.3.3.3. Chitosan
        • 4.7.1.3.3.4. PHMB
        • 4.7.1.3.3.5. Others
    • 4.7.1.4. Surgical Wound Care
      • 4.7.1.4.1. Surgical wound care market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
      • 4.7.1.4.2. Sutures & staples
      • 4.7.1.4.3. Tissue adhesive and sealants
      • 4.7.1.4.4. Anti-infective dressing
    • 4.7.1.5. Traditional Wound Care
      • 4.7.1.5.1. Traditional wound care market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
      • 4.7.1.5.2. Medical Tapes
      • 4.7.1.5.3. Cotton
      • 4.7.1.5.4. Bandages
      • 4.7.1.5.5. Gauzes
      • 4.7.1.5.6. Sponges
      • 4.7.1.5.7. Cleansing Agents
  • 4.7.2. Drug Delivery Products
    • 4.7.2.1. Drug delivery products market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.2.2. Inhalers
      • 4.7.2.2.1. Inhalers market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
      • 4.7.2.2.2. Metered-dose inhalers (MDIs)
      • 4.7.2.2.3. Dry powder inhalers (DPIs)
    • 4.7.2.3. Injection Devices
      • 4.7.2.3.1. Injection Devices market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
      • 4.7.2.3.2. Prefilled syringes
      • 4.7.2.3.3. Auto-injectors
    • 4.7.2.4. Transdermal patches
      • 4.7.2.4.1. Transdermal patches market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.2.5. Others
    • 4.7.2.6. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
  • 4.7.3. Diagnostic and Laboratory Disposables
    • 4.7.3.1. Diagnostic and laboratory disposables market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.3.2. Pipettes
      • 4.7.3.2.1. Pipettes market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.3.3. Tips
      • 4.7.3.3.1. Tips market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.3.4. Tubes
      • 4.7.3.4.1. Tubes market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.3.5. Cuvettes
      • 4.7.3.5.1. Cuvettes market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.3.6. Dishes
      • 4.7.3.6.1. Dishes market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.3.7. Cell Imaging Consumables
      • 4.7.3.7.1. Cell imaging consumables market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.3.8. Cell Culture Consumables
      • 4.7.3.8.1. Cell culture consumables market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.3.9. Specimen Containers
      • 4.7.3.9.1. Specimen containers market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.3.10. Transport Vials
      • 4.7.3.10.1. Transport vials market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.3.11. Collection and Transport Swabs
      • 4.7.3.11.1. Collection and transport swabs market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.3.12. Tissue Collectors
      • 4.7.3.12.1. Tissue collectors market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.3.13. Optical Grade
      • 4.7.3.13.1. Optical grade market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.3.14. Others
      • 4.7.3.14.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
  • 4.7.4. Dialysis Disposables
    • 4.7.4.1. Dialysis disposables market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.4.2. Dialysis Catheters
      • 4.7.4.2.1. Dialysis Catheters market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
      • 4.7.4.2.2. Tunneled catheters
      • 4.7.4.2.3. Non-tunneled catheters
    • 4.7.4.3. AV Access Needles
      • 4.7.4.3.1. AV Access Needles market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
      • 4.7.4.3.2. Dialysis fistula needles
      • 4.7.4.3.3. Safety needles
    • 4.7.4.4. Peritoneal Dialysis Consumables
      • 4.7.4.4.1. Peritoneal Dialysis Consumables market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
      • 4.7.4.4.2. PD drainage bags
      • 4.7.4.4.3. Transfer sets
      • 4.7.4.4.4. Others
    • 4.7.4.5. Others
      • 4.7.4.5.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
  • 4.7.5. Incontinence Products
    • 4.7.5.1. Incontinence products market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.5.2. Absorbent Products
      • 4.7.5.2.1. Absorbent products market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
      • 4.7.5.2.2. Pads & Guards
      • 4.7.5.2.3. Underwear & Briefs
      • 4.7.5.2.4. Bed Protectors
      • 4.7.5.2.5. Diapers
        • 4.7.5.2.5.1. Ultra-Absorbent Disposable Diapers
        • 4.7.5.2.5.2. Super-Absorbent Disposable Diapers
        • 4.7.5.2.5.3. Biodegradable Disposable Diapers
        • 4.7.5.2.5.4. Others
      • 4.7.5.2.6. Other Absorbents
    • 4.7.5.3. Catheters
      • 4.7.5.3.1. Catheters market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
      • 4.7.5.3.2. Intermittent Catheters
      • 4.7.5.3.3. Indwelling Catheters
      • 4.7.5.3.4. External Catheters
    • 4.7.5.4. Drainage Bags
      • 4.7.5.4.1. Drainage Bags market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.5.5. Skin Care & Hygiene Products
      • 4.7.5.5.1. Skin care & hygiene products market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
      • 4.7.5.5.2. Disposable wipes (incontinence wipes)
      • 4.7.5.5.3. Cleansing foams
      • 4.7.5.5.4. Others
    • 4.7.5.6. Others
      • 4.7.5.6.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
  • 4.7.6. Respiratory Supplies
    • 4.7.6.1. Respiratory supplies market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.6.2. Tracheostomy tubes
      • 4.7.6.2.1. Tracheostomy tubes market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.6.3. Disposable endotracheal tubes
      • 4.7.6.3.1. Disposable endotracheal tubes market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.6.4. Resuscitators
      • 4.7.6.4.1. Resuscitators market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.6.5. Disposable oxygen masks
      • 4.7.6.5.1. Disposable oxygen masks market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.6.6. Oxygen cannula
      • 4.7.6.6.1. Oxygen cannula market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.6.7. Others
      • 4.7.6.7.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
  • 4.7.7. Sterilization Supplies
    • 4.7.7.1. Sterilization supplies market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.7.2. Sterilization Indicators
      • 4.7.7.2.1. Sterilization indicators market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
      • 4.7.7.2.2. Chemical indicators
      • 4.7.7.2.3. Biological indicators
    • 4.7.7.3. Sterilization Packaging Supplies
      • 4.7.7.3.1. Sterilization packaging supplies market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
      • 4.7.7.3.2. Sterilization wraps
      • 4.7.7.3.3. Sterilization pouches
      • 4.7.7.3.4. Sterilization reels
    • 4.7.7.4. Disposable Sterilization Accessories
      • 4.7.7.4.1. Disposable sterilization accessories market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
  • 4.7.8. Non-woven Disposables
    • 4.7.8.1. Non-woven disposables market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
  • 4.7.9. Disposable Masks
    • 4.7.9.1. Disposable masks market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.9.2. Surgical & Procedure Masks
      • 4.7.9.2.1. Surgical & procedure masks market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.9.3. Respirator Masks
      • 4.7.9.3.1. Respirator masks market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.9.4. Other Medical Masks
      • 4.7.9.4.1. Other medical masks market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
  • 4.7.10. Disposable Eye Gear
    • 4.7.10.1. Disposable eye gear market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.10.2. Protective Safety Eyewear
      • 4.7.10.2.1. Protective safety eyewear market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
      • 4.7.10.2.2. Safety glasses
      • 4.7.10.2.3. Anti-fog safety glasses
      • 4.7.10.2.4. Splash-resistant goggles
    • 4.7.10.3. Surgical & Procedure Eye Protection
      • 4.7.10.3.1. Surgical & procedure eye protection market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.10.4. Laser Safety Eyewear (Disposable)
      • 4.7.10.4.1. Laser safety eyewear (disposable) market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.10.5. Post-Operative Eye Protection
      • 4.7.10.5.1. Post-operative eye protection market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
  • 4.7.11. Disposable Gloves
    • 4.7.11.1. Disposable gloves market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.11.2. Examination
      • 4.7.11.2.1. Examination market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.11.3. Surgical
      • 4.7.11.3.1. Surgical market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
  • 4.7.12. Hand Sanitizers
    • 4.7.12.1. Hand sanitizers market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.12.2. Gel
      • 4.7.12.2.1. Gel market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.12.3. Foam
      • 4.7.12.3.1. Foam market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.12.4. Liquid
      • 4.7.12.4.1. Liquid market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.12.5. Others
      • 4.7.12.5.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
  • 4.7.13. Others
    • 4.7.13.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.13.2. Disposable Hospital Gowns
      • 4.7.13.2.1. Disposable hospital gowns market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
      • 4.7.13.2.2. Surgical Gowns
        • 4.7.13.2.2.1. Fluid Resistant Gowns
          • 4.7.13.2.2.1.1. AAMI-rated
            • 4.7.13.2.2.1.1.1. Level 1
            • 4.7.13.2.2.1.1.2. Level 2
            • 4.7.13.2.2.1.1.3. Level 3
            • 4.7.13.2.2.1.1.4. Level 4
        • 4.7.13.2.2.2. Non-AAMI rated
        • 4.7.13.2.2.3. Non-Fluid Resistant Gowns (Non-AAMI rated)
      • 4.7.13.2.3. Non-Surgical Gowns
      • 4.7.13.2.4. Patient Gowns
    • 4.7.13.3. Emesis Bags
      • 4.7.13.3.1. Emesis bags market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.13.4. Shoe Covers & Caps
      • 4.7.13.4.1. Shoe covers & caps market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.13.5. Disposable Bed Sheets & Covers
      • 4.7.13.5.1. Disposable bed sheets & covers market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)
    • 4.7.13.6. Others
      • 4.7.13.6.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP Volume)

Chapter 5. Medical Disposables Market: Raw Material Estimates & Trend Analysis

• 5.1. Definitions and Scope
• 5.2. Raw Material Market Share, 2021 & 2033
• 5.3. Segment Dashboard
• 5.4. Global Medical Disposables Market by Raw Material Outlook
• 5.5. Market Size & Forecasts and Trend Analyses, 2025 to 2033 for the following
  • 5.5.1. Plastic Resin
    • 5.5.1.1. Plastic resin market estimates and forecast 2021 to 2033 (USD Million)
  • 5.5.2. Nonwoven Material
    • 5.5.2.1. Nonwoven material market estimates and forecast 2021 to 2033 (USD Million)
  • 5.5.3. Rubber
    • 5.5.3.1. Rubber market estimates and forecast 2021 to 2033 (USD Million)
  • 5.5.4. Paper and Paperboard
    • 5.5.4.1. Paper and paperboard market estimates and forecast 2021 to 2033 (USD Million)
  • 5.5.5. Metals
    • 5.5.5.1. Metals market estimates and forecast 2021 to 2033 (USD Million)
  • 5.5.6. Glass
    • 5.5.6.1. Glass market estimates and forecast 2021 to 2033 (USD Million)
  • 5.5.7. Others
    • 5.5.7.1. Others market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. Medical Disposables Market: End Use Estimates & Trend Analysis

• 6.1. Definitions and Scope
• 6.2. End Use Market Share, 2021 & 2033
• 6.3. Segment Dashboard
• 6.4. Global Medical Disposables Market by End Use Outlook
• 6.5. Market Size & Forecasts and Trend Analyses, 2025 to 2033 for the following
  • 6.5.1. Hospitals
    • 6.5.1.1. Hospitals market estimates and forecast 2021 to 2033 (USD Million)
  • 6.5.2. Home Healthcare
    • 6.5.2.1. Home healthcare market estimates and forecast 2021 to 2033 (USD Million)
  • 6.5.3. Outpatient/Primary Care Facilities
    • 6.5.3.1. Outpatient/primary care facilities market estimates and forecast 2021 to 2033 (USD Million)
  • 6.5.4. Others
    • 6.5.4.1. Others market estimates and forecast 2021 to 2033 (USD Million)

Chapter 7. Medical Disposables Market: Regional Estimates & Trend Analysis, by Product, by Raw Material, and by End Use

• 7.1. Regional market share analysis, 2025 & 2033
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Market Size & Forecasts, and Trend Analysis, 2021 to 2033:
• 7.5. North America
  • 7.5.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Competitive scenario
    • 7.5.2.3. Regulatory framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. U.S. market estimates and forecasts, 2021 - 2033
  • 7.5.3. Canada
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Competitive scenario
    • 7.5.3.3. Regulatory framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Canada market estimates and forecasts, 2021 - 2033
  • 7.5.4. Mexico
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Competitive scenario
    • 7.5.4.3. Regulatory framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. Mexico market estimates and forecasts, 2021 - 2033
• 7.6. Europe
  • 7.6.1. Germany
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Competitive scenario
    • 7.6.1.3. Regulatory framework
    • 7.6.1.4. Reimbursement scenario
    • 7.6.1.5. Germany market estimates and forecasts, 2021 - 2033
  • 7.6.2. UK
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Regulatory framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. UK market estimates and forecasts, 2021 - 2033
  • 7.6.3. France
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive scenario
    • 7.6.3.3. Regulatory framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. France market estimates and forecasts, 2021 - 2033
  • 7.6.4. Italy
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Competitive scenario
    • 7.6.4.3. Regulatory framework
    • 7.6.4.4. Reimbursement scenario
    • 7.6.4.5. Italy market estimates and forecasts, 2021 - 2033
  • 7.6.5. Spain
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Competitive scenario
    • 7.6.5.3. Regulatory framework
    • 7.6.5.4. Reimbursement scenario
    • 7.6.5.5. Spain market estimates and forecasts, 2021 - 2033
  • 7.6.6. Denmark
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Competitive scenario
    • 7.6.6.3. Regulatory framework
    • 7.6.6.4. Reimbursement scenario
    • 7.6.6.5. Denmark market estimates and forecasts, 2021 - 2033
  • 7.6.7. Sweden
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Competitive scenario
    • 7.6.7.3. Regulatory framework
    • 7.6.7.4. Reimbursement scenario
    • 7.6.7.5. Sweden market estimates and forecasts, 2021 - 2033
  • 7.6.8. Norway
    • 7.6.8.1. Key country dynamics
    • 7.6.8.2. Competitive scenario
    • 7.6.8.3. Regulatory framework
    • 7.6.8.4. Reimbursement scenario
    • 7.6.8.5. Norway market estimates and forecasts, 2021 - 2033
  • 7.6.9. Netherlands
    • 7.6.9.1. Key country dynamics
    • 7.6.9.2. Competitive scenario
    • 7.6.9.3. Regulatory framework
    • 7.6.9.4. Reimbursement scenario
    • 7.6.9.5. Netherlands market estimates and forecasts, 2021 - 2033
• 7.7. Asia Pacific
  • 7.7.1. China
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Competitive scenario
    • 7.7.1.3. Regulatory framework
    • 7.7.1.4. Reimbursement scenario
    • 7.7.1.5. China market estimates and forecasts, 2021 - 2033
  • 7.7.2. Japan
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Japan market estimates and forecasts, 2021 - 2033
  • 7.7.3. India
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Regulatory framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. India market estimates and forecasts, 2021 - 2033
  • 7.7.4. Australia
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Competitive scenario
    • 7.7.4.3. Regulatory framework
    • 7.7.4.4. Reimbursement scenario
    • 7.7.4.5. Australia market estimates and forecasts, 2021 - 2033
  • 7.7.5. South Korea
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Competitive scenario
    • 7.7.5.3. Regulatory framework
    • 7.7.5.4. Reimbursement scenario
    • 7.7.5.5. South Korea market estimates and forecasts, 2021 - 2033
  • 7.7.6. Thailand
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Competitive scenario
    • 7.7.6.3. Regulatory framework
    • 7.7.6.4. Reimbursement scenario
    • 7.7.6.5. Thailand market estimates and forecasts, 2021 - 2033
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Competitive scenario
    • 7.8.1.3. Regulatory framework
    • 7.8.1.4. Reimbursement scenario
    • 7.8.1.5. Brazil market estimates and forecasts, 2021 - 2033
  • 7.8.2. Argentina
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Competitive scenario
    • 7.8.2.3. Regulatory framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. Argentina market estimates and forecasts, 2021 - 2033
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Competitive scenario
    • 7.9.1.3. Regulatory framework
    • 7.9.1.4. Reimbursement scenario
    • 7.9.1.5. South Africa market estimates and forecasts, 2021 - 2033
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Competitive scenario
    • 7.9.2.3. Regulatory framework
    • 7.9.2.4. Reimbursement scenario
    • 7.9.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033
  • 7.9.3. UAE
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Competitive scenario
    • 7.9.3.3. Regulatory framework
    • 7.9.3.4. Reimbursement scenario
    • 7.9.3.5. UAE market estimates and forecasts, 2021 - 2033
  • 7.9.4. Kuwait
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Competitive scenario
    • 7.9.4.3. Regulatory framework
    • 7.9.4.4. Reimbursement scenario
    • 7.9.4.5. Kuwait market estimates and forecasts, 2021 - 2033

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key company market share analysis, 2025, by Segment
  • 8.3.3. BD
    • 8.3.3.1. Company overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Product benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. 3M
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Medline Industries, Inc.
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Smith+Nephew
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Cardinal Health
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Bayer AG
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Stryker
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Molnlycke AB (Investor AB)
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Henkel
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. Advin Health Care
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives
  • 8.3.13. Asahi Kasei Corporation
    • 8.3.13.1. Company overview
    • 8.3.13.2. Financial performance
    • 8.3.13.3. Product benchmarking
    • 8.3.13.4. Strategic initiatives
  • 8.3.14. ANSELL LTD.
    • 8.3.14.1. Company overview
    • 8.3.14.2. Financial performance
    • 8.3.14.3. Product benchmarking
    • 8.3.14.4. Strategic initiatives
  • 8.3.15. Coloplast Group
    • 8.3.15.1. Company overview
    • 8.3.15.2. Financial performance
    • 8.3.15.3. Product benchmarking
    • 8.3.15.4. Strategic initiatives
  • 8.3.16. B. Braun SE
    • 8.3.16.1. Company overview
    • 8.3.16.2. Financial performance
    • 8.3.16.3. Product benchmarking
    • 8.3.16.4. Strategic initiatives
  • 8.3.17. Hollister Incorporated
    • 8.3.17.1. Company overview
    • 8.3.17.2. Financial performance
    • 8.3.17.3. Product benchmarking
    • 8.3.17.4. Strategic initiatives
  • 8.3.18. ConvaTec Group Plc
    • 8.3.18.1. Company overview
    • 8.3.18.2. Financial performance
    • 8.3.18.3. Product benchmarking
    • 8.3.18.4. Strategic initiatives
  • 8.3.19. Salts Healthcare Ltd.
    • 8.3.19.1. Company overview
    • 8.3.19.2. Financial performance
    • 8.3.19.3. Product benchmarking
    • 8.3.19.4. Strategic initiatives
  • 8.3.20. Essity Aktiebolag
    • 8.3.20.1. Company overview
    • 8.3.20.2. Financial performance
    • 8.3.20.3. Product benchmarking
    • 8.3.20.4. Strategic initiatives
  • 8.3.21. Paul Hartmann AG
    • 8.3.21.1. Company overview
    • 8.3.21.2. Financial performance
    • 8.3.21.3. Product benchmarking
    • 8.3.21.4. Strategic initiatives
  • 8.3.22. Encompass Group, LLC.
    • 8.3.22.1. Company overview
    • 8.3.22.2. Financial performance
    • 8.3.22.3. Product benchmarking
    • 8.3.22.4. Strategic initiatives
  • 8.3.23. Nippon Encon Manufacturing Co., Ltd.
    • 8.3.23.1. Company overview
    • 8.3.23.2. Financial performance
    • 8.3.23.3. Product benchmarking
    • 8.3.23.4. Strategic initiatives
  • 8.3.24. Owens & Minor (Platinum Equity)
    • 8.3.24.1. Company overview
    • 8.3.24.2. Financial performance
    • 8.3.24.3. Product benchmarking
    • 8.3.24.4. Strategic initiatives
  • 8.3.25. Henry Schein, Inc.
    • 8.3.25.1. Company overview
    • 8.3.25.2. Financial performance
    • 8.3.25.3. Product benchmarking
    • 8.3.25.4. Strategic initiatives
  • 8.3.26. Boston Scientific Corporation
    • 8.3.26.1. Company overview
    • 8.3.26.2. Financial performance
    • 8.3.26.3. Product benchmarking
    • 8.3.26.4. Strategic initiatives
  • 8.3.27. Teleflex Incorporated
    • 8.3.27.1. Company overview
    • 8.3.27.2. Financial performance
    • 8.3.27.3. Product benchmarking
    • 8.3.27.4. Strategic initiatives
  • 8.3.28. Medtronic
    • 8.3.28.1. Company overview
    • 8.3.28.2. Financial performance
    • 8.3.28.3. Product benchmarking
    • 8.3.28.4. Strategic initiatives
  • 8.3.29. Amsino International, Inc.
    • 8.3.29.1. Company overview
    • 8.3.29.2. Financial performance
    • 8.3.29.3. Product benchmarking
    • 8.3.29.4. Strategic initiatives
  • 8.3.30. HR HealthCare
    • 8.3.30.1. Company overview
    • 8.3.30.2. Financial performance
    • 8.3.30.3. Product benchmarking
    • 8.3.30.4. Strategic initiatives
  • 8.3.31. Dynarex Corporation
    • 8.3.31.1. Company overview
    • 8.3.31.2. Financial performance
    • 8.3.31.3. Product benchmarking
    • 8.3.31.4. Strategic initiatives
  • 8.3.32. Sterimed Group.
    • 8.3.32.1. Company overview
    • 8.3.32.2. Financial performance
    • 8.3.32.3. Product benchmarking
    • 8.3.32.4. Strategic initiatives
  • 8.3.33. Well Lead Medical Co., Ltd.
    • 8.3.33.1. Company overview
    • 8.3.33.2. Financial performance
    • 8.3.33.3. Product benchmarking
    • 8.3.33.4. Strategic initiatives